Eliane Schutte, Xeltis - Transformative Vascular Implants | LSI Europe '24

Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Eliane Schutte
Eliane Schutte
CEO, Xeltis